Testosterone Сypionate: Relief you can feel, but what about fertility?

Testosterone cypionate can relieve true hypogonadism, which is diagnosed in men with persistent symptoms plus consistently low testosterone on repeated morning testing. However, it commonly suppresses LH and FSH and can sharply reduce or shut down sperm production. Learn how it is dosed and monitored to mimic normal physiology, and how to plan ahead if fertility matters to you.

Key takeaways

• Testosterone cypionate can improve libido, energy, and mood in men with confirmed hypogonadism. It commonly suppresses fertility by shutting down the hormone signals needed for sperm production.
• By raising blood testosterone, testosterone cypionate triggers negative feedback that lowers GnRH, LH, and FSH. This reduces intratesticular testosterone and can drive sperm counts sharply down (sometimes near zero), with possible testicular shrinkage.
• The men most likely to benefit have persistent symptoms plus biochemical evidence of hypogonadism on repeated morning testing.
• Free testosterone, measured by equilibrium dialysis or estimated with an accurate formula, helps when total testosterone is borderline or SHBG is altered. Baseline LH and FSH drawn at the same time show whether the problem starts in the testes or in the brain.
• Male contraceptive studies show testosterone injections can suppress sperm counts below 1 million/mL in many men. Sperm recovery after stopping often takes 3 to 12 months, and sometimes longer after longer use.

The relationship

Testosterone cypionate is an injectable testosterone ester used to treat hypogonadism. It is usually injected into a muscle, though some clinicians use injections under the skin. It releases testosterone gradually over the days after each dose. According to the Endocrine Society’s 2018 clinical practice guideline, hypogonadism should be diagnosed only in men who have both of the following:^[1]

• Symptoms and signs of testosterone deficiency, such as low libido, fatigue, and depressed mood
• Consistently low testosterone confirmed on repeated morning testing

The 2018 AUA guideline on testosterone deficiency advises measuring luteinizing hormone (LH) in men with low testosterone.^[2] LH helps separate a problem in the testes from a signaling problem in the brain.

The Endocrine Society guideline recommends measuring free testosterone in two situations: when total testosterone is near the lower limit of normal, or when a condition alters sex hormone-binding globulin (SHBG).^[1] Free testosterone can be measured by equilibrium dialysis or estimated with an accurate formula.

The main trade-off is fertility. Testosterone cypionate suppresses LH and follicle-stimulating hormone (FSH), the pituitary hormones that tell the testes to make testosterone and sperm. When those signals fall, the testes’ own testosterone production drops and sperm counts often fall sharply. The Endocrine Society guideline therefore recommends against starting testosterone therapy in men who are planning fertility in the near term.^[1]

How it works

A slow-release testosterone ester

Testosterone cypionate is testosterone attached to a cypionate ester, a chemical side chain that slows release from the injection site. Enzymes gradually remove the ester, so blood testosterone rises over the first few days after an injection and then declines until the next dose. How high it peaks and how fast it falls depend on the dose, the injection site, and individual metabolism.

Because levels rise and fall between doses, smaller, more frequent injections produce steadier levels than larger doses given every 1 to 2 weeks. They lower the peaks and raise the troughs. Steadier levels may mean fewer swings in mood and libido.

How it turns down the brain’s signals

The hypothalamic pituitary gonadal axis is the hormone loop connecting the brain and testes. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which tells the pituitary gland to release LH and FSH. LH tells the testes to make testosterone, and FSH helps drive sperm production.

Adding testosterone cypionate raises blood testosterone. The brain senses this and lowers GnRH, LH, and FSH output through negative feedback, the same loop that keeps testosterone in range in healthy men. With less LH and FSH, the testes make less testosterone and often get smaller over time.

Effects on sperm production and fertility

Spermatogenesis, the production of sperm inside the testes, depends on two things: FSH, and a testosterone level inside the testicles that is much higher than the level measured in blood. Suppressing LH and FSH removes both.

Male contraceptive research shows how large this effect can be. A 2008 integrated analysis in the Journal of Clinical Endocrinology and Metabolism pooled individual data from 30 studies of 1,756 healthy men given testosterone, with or without a progestin.^[3] It examined how quickly and how completely sperm output fell to 1 million per milliliter or less, the level used as the contraceptive target, and found that adding a progestin made suppression faster and more complete.^[3]

A 2006 integrated analysis in The Lancet followed recovery in 1,549 healthy men after they stopped hormonal contraceptive regimens.^[4] Sperm concentration returned to 20 million per milliliter within 6 months in about two thirds of men and within 12 months in about 90 percent.^[4] In the same analysis, shorter treatment and shorter-acting testosterone preparations were linked to faster recovery.^[4] These were healthy volunteers treated for limited periods. Recovery after years of therapy for hypogonadism may be slower and less predictable.

Primary or secondary hypogonadism

Measuring LH and FSH along with testosterone at baseline classifies the problem:

• High LH with low testosterone suggests primary hypogonadism, where the testes are not responding.
• Low or normal LH with low testosterone suggests secondary or functional hypogonadism, where the brain’s signal is weak and the testes are usually intact.

The classification changes treatment. Primary hypogonadism is usually treated with testosterone, because the testes cannot respond to more stimulation. In secondary or functional hypogonadism, testosterone therapy also raises levels, but it suppresses the axis further. Drugs that raise the body’s own LH and FSH are an alternative, especially for men who want to keep their fertility. Functional causes such as obesity, type 2 diabetes, and certain medications can also improve when the underlying condition is treated.

Routes of injection and dose considerations

Testosterone cypionate can be injected into the gluteal or thigh muscles, or into the fat just under the skin. Subcutaneous injection can produce testosterone levels similar to intramuscular injection, and many men find it less painful.

The Endocrine Society guideline suggests aiming for testosterone concentrations in the mid-normal range during treatment.^[1] It advises taking the formulation, patient preference, and side effects into account.^[1] Doses are individualized. In practice, weekly totals of roughly 80 to 150 mg, split into two or more injections, are common. Doses that push levels above the normal range raise the risk of high hematocrit, acne, and irritability.

Conditions linked to it

Used for the wrong reasons or without monitoring, testosterone cypionate can cause or worsen several problems.

• Fertility suppression: Testosterone lowers sperm output so reliably that male hormonal contraceptive research is built on this effect.^[3] In men using it for hypogonadism, the same effect can cause temporary infertility.
• Elevated red blood cell count: Testosterone stimulates erythropoiesis, or red blood cell production. This can lead to polycythemia, an abnormally high hematocrit (the proportion of red cells in blood), which raises concern for blood clots. The Endocrine Society guideline lists elevated hematocrit as a reason not to start therapy and includes hematocrit in routine monitoring.^[1] It advises stopping therapy if hematocrit rises above 54 percent and restarting at a lower dose once it falls.^[1]
• Prostate-related concerns: A 2020 historical review in Sexual Medicine Reviews traces decades of concern that testosterone activates prostate cancer.^[5] It describes how that concern eased as accumulated evidence showed testosterone therapy was not associated with increased prostate cancer risk.^[5] PSA can still rise after starting therapy. The Endocrine Society guideline recommends against starting testosterone without further urological evaluation in these men:^[1]
  • Men with prostate cancer or a palpable prostate nodule
  • Men with PSA above 4 ng/mL
  • Men at higher risk with PSA above 3 ng/mL

  It also calls for evaluating prostate cancer risk during the first year of treatment.^[1]

• Cardiovascular risk signals: In the 2023 TRAVERSE trial in the New England Journal of Medicine, testosterone was noninferior to placebo for major cardiovascular events.^[6] The trial enrolled 5,246 men aged 45 to 80 with hypogonadism and existing or high cardiovascular risk, followed for a mean of 33 months.^[6] The testosterone group had more atrial fibrillation, acute kidney injury, and pulmonary embolism. TRAVERSE used a daily testosterone gel, so it did not test injections directly.^[6] The Endocrine Society guideline recommends against starting therapy in men with uncontrolled heart failure or a heart attack or stroke within the past 6 months.^[1]
• Mood and sleep changes: Many men report better mood, less irritability, and improved sleep on well-dosed testosterone cypionate, especially if they started with depression or fatigue linked to low testosterone. Very high peaks, however, can trigger irritability, anxiety, or insomnia. Sleep apnea may worsen on therapy. The Endocrine Society guideline recommends against starting testosterone in men with untreated severe obstructive sleep apnea.^[1]

Much of the older cardiovascular and prostate literature was observational. Newer randomized data are more reassuring for appropriately selected men treated to physiologic levels. Even so, dose, age, other illnesses, and adverse effects such as elevated hematocrit can change the risk picture over time, so follow-up remains necessary.

Symptoms and signals

Men usually come to testosterone cypionate because they feel off, not because of a lab number.

Symptoms and labs need to be read together. Many of the signs below overlap with common issues, including:

• Sleep deprivation or untreated sleep apnea
• Overtraining
• Depression
• Thyroid disease
• Medication side effects, especially from opioids

If you are investigating low testosterone, check morning total testosterone on at least two separate days and draw LH and FSH with the baseline testosterone panel. Add free testosterone when total testosterone is borderline or SHBG may be altered. Avoid diagnosing from one test or one symptom cluster.

Seek urgent care if you develop any of these symptoms:

• Chest pain
• Sudden shortness of breath
• Coughing up blood
• One-sided leg swelling or pain
• Fainting
• Sudden neurologic symptoms, such as weakness on one side or trouble speaking

This matters most if your hematocrit is elevated or you recently increased your dose. These can be warning signs of serious heart, lung, or clotting events and should not be “watched at home.”

Symptoms that may suggest low testosterone before treatment:

• Low sex drive or less interest in sex than usual
• Fewer morning erections
• Trouble getting or keeping an erection despite stimulation
• Low energy or “crashing” by mid-afternoon
• Loss of muscle mass or strength despite training
• Increased body fat, especially around the waist
• Low mood, irritability, or a “flat” feeling
• Brain fog, trouble focusing, or slower thinking
• Reduced shaving frequency or body hair growth
• Smaller testicles or reduced firmness in the scrotum

Signals to watch once you start testosterone cypionate:

• Improving libido, energy, and mood in the first 4 to 12 weeks
• Changes in testicle size or scrotal “fullness,” which often decrease
• Acne, oily skin, or increased body hair
• Swelling in the ankles or sudden weight gain from fluid retention
• Shortness of breath, headaches, or facial redness, which can signal high hematocrit
• Worsening snoring, gasping at night, or daytime sleepiness, suggesting possible sleep apnea
• Breast tenderness or swelling related to changes in estradiol in some men
• Changes in mood, such as feeling more on edge, especially right after injections

If you are trying to conceive, you will not feel your sperm count dropping. The only way to track the effect on fertility is a semen analysis before starting therapy and at intervals afterward.

What to do about it

Before considering testosterone cypionate, clarify your goal: symptom relief, body composition, sexual function, or fertility planning. If you may want to conceive in the near term, the Endocrine Society guideline recommends against starting testosterone therapy.^[1] In that case, talk with a clinician first about a baseline semen analysis and fertility-preserving alternatives such as enclomiphene.

1. Get properly tested before you start
   • Test morning total testosterone on at least 2 separate days, early in the morning when levels are highest. The AUA guideline uses a total testosterone below 300 ng/dL on two early morning measurements as a reasonable cutoff to support the diagnosis.^[2]
   • According to the Endocrine Society guideline, free testosterone should be measured by equilibrium dialysis or estimated with an accurate formula when total testosterone is near the lower limit of normal or SHBG may be altered.^[1]
   • Draw LH and FSH with your baseline testosterone panel. High LH with low testosterone suggests primary hypogonadism, while low or normal LH with low testosterone suggests secondary or functional hypogonadism. The AUA guideline advises checking prolactin when testosterone is low and LH is low or low normal.^[2]
   • Get baseline hematocrit and PSA, especially if you are over 40 or have urinary symptoms. A clinician may also consider a digital rectal exam if you have prostate symptoms or an abnormal PSA.
   • If you care about future fertility, get a semen analysis before starting testosterone cypionate. Freezing sperm before therapy is a reasonable safety net for men who may delay having children.
2. Use lifestyle and the right kind of treatment
   • Work on the basics: sleep at least 7 hours, maintain a healthy weight, strength train 2 to 3 times per week, and cut back on excess alcohol. Weight loss can raise testosterone in men with obesity, though the increase is usually modest.
   • If persistent symptoms and low testosterone come with low or normal LH, the testes are usually intact. Treatments that stimulate the body’s own LH and FSH can raise testosterone without suppressing sperm production the way external testosterone does. Enclomiphene, the purified trans isomer, works this way.
   • If symptoms and low testosterone come with high LH, primary hypogonadism is more likely, and testosterone therapy such as testosterone cypionate is the usual option.
3. Monitor and adjust over time
   • The Endocrine Society guideline calls for a standardized monitoring plan during the first year after starting testosterone cypionate. The plan covers symptoms, side effects, serum testosterone, hematocrit, and prostate cancer risk.^[1]
   • If hematocrit rises above 54 percent, the same guideline advises stopping therapy until it falls, checking for sleep apnea and low oxygen, and restarting at a lower dose.^[1]
   • Keep simple notes on libido, energy, mood, sleep, and gym performance. Dose changes should be guided by both labs and how you feel.
   • If you decide to stop testosterone cypionate, plan it with your clinician. When fertility is the immediate goal, especially after long-term therapy, hCG is more often used. When it is not, enclomiphene is an alternative some men use to support recovery of natural production.

Veedma offers testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of labs you already have, interpreted by licensed providers. In Veedma’s protocol, persistent symptoms with free testosterone below 100 pg/mL support treatment, and providers prescribe enclomiphene or the enclomiphene plus tadalafil tablet when appropriate. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.

Myth vs fact

Myth: Testosterone cypionate is basically a natural supplement.

Fact: It is a prescription hormone drug that substantially alters your endocrine system and can shut down sperm production. Over-the-counter boosters are not comparable in potency or risk.

Myth: Once you start testosterone cypionate, you can never come off it.

Fact: Many men can stop and recover natural production, especially after shorter courses. Recovery can take months and may be incomplete in some men, so it matters to start for the right reasons.

Myth: If a little testosterone helps, more is always better.

Fact: The Endocrine Society guideline suggests aiming for mid-normal testosterone levels during treatment.^[1] Levels far above normal add side effects such as high hematocrit, acne, and irritability without proven health benefit.

Myth: If my libido is low, testosterone cypionate is the obvious fix.

Fact: Low desire has many causes, including stress, relationship issues, depression, medications, and sleep problems. Testosterone helps most when low libido occurs alongside confirmed low testosterone, not in isolation. Non-hormonal causes deserve a look as well.

Bottom line

Testosterone cypionate can substantially improve sexual desire, energy, and mood in men with true hypogonadism when it is dosed to mirror normal physiology. The same drug can temporarily switch off sperm production. Used casually, at high doses, or without monitoring, it can also raise health risks. If you are thinking about testosterone cypionate, base the decision on repeated testing and clear symptoms. Then make a plan that accounts for both your current health and your future fertility.

References

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715-1744. PMID: 29562364
2. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200:423-432. PMID: 29601923
3. Liu PY, Swerdloff RS, Anawalt BD, et al. Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab. 2008;93:1774-83. PMID: 18303073
4. Liu PY, Swerdloff RS, Christenson PD, et al. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367:1412-20. PMID: 16650651
5. Morgentaler A, Traish A. The History of Testosterone and the Evolution of its Therapeutic Potential. Sex Med Rev. 2020;8:286-296. PMID: 29661690
6. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389:107-117. PMID: 37326322